stockrowActinium Pharmaceuticals, Inc. (ATNM) vs Hyperion DeFi, Inc. (HYPD)
- Actinium Pharmaceuticals, Inc. ATNM 1.42 +9.23%
- Hyperion DeFi, Inc. HYPD 2.52 −1.56%
Actinium Pharmaceuticals, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Hyperion DeFi, Inc. are of similar size ($40.9M and $39.8M). Hyperion DeFi, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against 1,990.6%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 18 metrics below, Actinium Pharmaceuticals, Inc. leads on 13 and Hyperion DeFi, Inc. on 5.
Valuation
Profitability
| Metric | ATNM | HYPD | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 78.35% | 68.51% |
| Operating margin | 27.20% | 314.32% | 0.00% |
| Net margin | 32.18% | (1,224.53%) | 0.00% |
| Free cash flow margin | (66.16%) | (5,509.35%) | 0.00% |
| Return on equity | 45.86% | (24.63%) | (51.96%) |
| Return on assets | 21.92% | (20.32%) | (46.06%) |
| Return on invested capital | 0.00% | 2.73% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack